MedTech Resources

Device type · LWP

Implantable Pulse Generator, Pacemaker (Non-Crt)

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about LWP: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

LWP

Cardiovascular

Device class

Class III

FDA decisions since 2015

2

510(k), De Novo and PMA

Adverse event reports

19,257

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Implantable Pulse Generator, Pacemaker (Non-Crt)
Product code
LWP
Device class
Class III
Review panel
Cardiovascular

Latest FDA decisions

All decisions for LWP

Reports received

19,257

Received Nov 1, 2025 to Nov 19, 2026. Includes 5 of another or unstated type.

Malfunction reports

11,682

61% of reports

Injury reports

7,492

39% of reports

Death reports

78

0.4% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2334248950
Jan 2439252950
Feb 2436752760
Mar 2437749531
Apr 2436950730
May 24375503102
Jun 2438851090
Jul 2435250170
Aug 2434847560
Sep 2435241320
Oct 2438848461
Nov 2436848270
Dec 2441051230
Jan 2529047290
Feb 2536655660
Mar 25396497100
Apr 2542249770
May 2537346780
Jun 25438443190
Jul 2538144251
Aug 2538839990
Sep 2537654550
Oct 2548189490
Nov 25496763140
Dec 2562096740
Jan 2668489010
Feb 2672988950
Mar 2688486360
Apr 261,18663740
May 261,08753390
Jun 261,258496120
Jul 261,39840970
Aug 2681529271
Sep 261,37141660
Oct 261,15433734
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Premature Discharge of Battery10,176
  • Adverse Event Without Identified Device or Use Problem1,876
  • Incorrect, Inadequate or Imprecise Result or Readings1,565
  • Interrogation Problem1,428
  • Over-Sensing1,386
  • Pacing Problem777
  • Failure to Capture772
  • Signal Artifact/Noise735
  • High impedance696
  • Use of Device Problem680

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions16,045
  • Unspecified Infection1,356
  • Insufficient Information438
  • Syncope/Fainting247
  • Discomfort213
  • Pocket Erosion196
  • Bradycardia181
  • Arrhythmia176
  • Asystole145
  • Dizziness139

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Boston Scientific Corporation

    Z-1770-2026 · Started Mar 19, 2026 · Posted by FDA Apr 24, 2026

    Reason given: Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding to include all CRT-P and dual-chamber extended life (DR-EL) devices. Dual chamber modes are...

    Cause as FDA categorized it: Nonconforming Material/Component

  • Boston Scientific Corporation

    Z-0079-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0080-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0081-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0082-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0083-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0084-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0085-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

Showing the 8 newest of 113 recall records in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.